Table 1.
Participant Characteristics | N=24 |
---|---|
| |
Mean (SD) | |
Age | 42.09 (13.23) |
BMI | 27.43 (5.66) |
PANAS negative affect | 21.67 9.74 |
Duration of symptoms in years | 7.21 (7.97) |
GUPI Score Total, 0-45 | 23.85 (8.69) |
GUPI pain subscale, 0-23, mean (SD) | 11.35 (5.03) |
GUPI urinary subscale, 0-10 | 6.33 (2.94) |
| |
Race % (n) | |
White | 96 (23) |
Asian | 4 (1) |
| |
Ethnicity % (n) | |
Non-Hispanic | 100 (24) |
| |
Education % (n) | |
High School or GED | 4 (1) |
Some College | 30 (7) |
Graduated College | 33 (8) |
Graduate Degree | 33 (8) |
| |
Employment % (n) | |
Employed | 83 (20) |
Disabled | 8 (2) |
Retired | 4 (1) |
Full Time Homemaker | 4 (1) |
| |
Annual Income/$ % (n) | |
<10,000 | 21 (5) |
<25,000 | 4 (1) |
<50,000 | 17 (4) |
<100,000 | 46 (11) |
>100,000 | 12 (3) |
| |
Comorbid Conditions % (n) | |
None | 33 (8) |
One or More (IBS, Fibromyalgia, TMD, vulvodynia, CFS) | 67 (16) |
| |
Tricyclic anti-depressants | |
No | 38 (9) |
Yes | 62 (15) |
| |
Opioids | |
No | 75 (18) |
Yes | 25 (6) |
| |
Pentosan Polysulfate | |
No | 33 (8) |
Yes | 67 (16) |
| |
NSAIDs | |
No | 96 (23) |
Yes | 4 (1) |
| |
SSRI/SNRIs | |
No | 88 (21) |
Yes | 12 (3) |
| |
Experiencing flare at baseline visit? | |
No | 67 (16) |
Yes | 33 (8) |
| |
GUPI Score Total, 0-45 | 23.85 (8.69) |
| |
GUPI pain subscale, 0-23, mean (SD) | 11.35 (5.03) |
| |
GUPI urinary subscale, 0-10 | 6.33 (2.94) |
BMI= Body Mass Index
CFS = Chronic Fatigue Syndrome
IBS= Irritable Bowel Syndrome
GUPI = Genitourinary Pain Index
NSAID = Non-Steroidal Anti-Inflammatory Drug
PANAS = Positive and Negative Affect Scale
TMD= Temporomandibular Disorder
SSRI/SNRI= Selective Serotonin/Norepinephrine Reuptake Inhibitor